Richard Faragher
Professor of Biogerontology at the University of Brighton
My work centres on the mechanisms and consequences of cellular senescence. Senescent cells are the living, but permanently non-dividing, forms of cells which are normally capable of division within mammalian tissues. Thus it is possible to have both growing and senescent forms of fibroblasts, keratinocytes, astrocytes, endothelial cells, vascular smooth muscle cells but not neurons or red blood cells. The senescent state is distinct from quiescence (transient growth arrest induced by contact inhibition or serum withdrawal), from cell death (senescent cells remain viable for many years) and from terminal differentiation. In vivo senescence primarily exists to limit the capacity for expansion of clones of cells and thus limit the opportunities for them to accumulate pro-carcinogenic mutations. When senescence was first observed in vitro in the early 1960s Leonard Hayflick proposed that the phenomenon was related to ageing. Although this theory was bitterly contested for decades it is now clear that the progressive accumulation of senescent cells is a major cause of ageing in mammals. I study three distinct aspects of this process.
Visit website: https://research.brighton.ac.uk/en/persons/richard-faragher
See also: University of Brighton - Public research university.
Details last updated 07-Sep-2019
Richard Faragher is also referenced in the following:
ARDD 2023 - 10th Aging Research & Drug Discovery Meeting
28-Aug-2023 to 01-Sep-2023
Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen
Richard Faragher News
Longevity.Technology interviews Prof Faragher about his cellular senescence research
Longevity Technology - 15-Jul-2020
Maybe we need to develop senoplasts like resveratrol as well as senolytics
Read more...Articles written by Richard Faragher
Science predicts that theoretically we can live up to 150 years
The Conversation (UK) - 08-Jun-2021
Is it time to find ways to make it our average life expectancy?
Read more...Improving immune system in the elderly with the existing medicines
The Conversation (UK) - 13-Oct-2020
Repurposing the potential existing drugs might eliminate the risk of developing infections
Read more...Unsurprising ways to increase UK life expectancy up to 5 years
The Conversation - 02-Mar-2020
Government taps doctors, scientists, and UK citizens' personal efforts to achieve this
Read more...